Death rates have decreased among people with high blood pressure but remain far higher than in those without it, according to research in Circulation: Journal of the American Heart Association.
"Mortality rates are going down for everybody with high blood pressure, but despite the availability of several types of medication to reduce blood pressure, there is still a large gap between those with hypertension and those without," said Earl S. Ford, M.D., M.P.H., study author and medical officer with the U.S. Public Health Service at the Centers for Disease Control and Prevention.
Ford examined changes in death rates among adults ages 25-74, using results from two national health surveys. The National Health and Nutrition Examination Survey (NHANES) I Epidemiologic Follow-up Study followed participants recruited between 1971 and 1975. The NHANES III Linked Mortality Study followed participants recruited between 1988 and 1994.
The study found:
"On average, hypertensive women had larger declines in their blood pressure than hypertensive men, but didn't do as well in other measures related to heart disease risk," Ford said. "Compared with hypertensive men, women gained more weight, were more likely to be diagnosed with diabetes and were less likely to quit smoking."
Between the two surveys, hypertensive patients had a:
"The mortality gap that remains despite improved treatment means that hypertensive patients need to be aggressively monitored for risk factors other than blood pressure, with efforts made to reduce the total burden of heart disease risks," Ford said.
"In addition to taking steps to lower your blood pressure, if you have hypertension, you should stop smoking, control your weight as well as you can, have your lipid levels measured (and if needed, be treated), and get tested for diabetes."
Author disclosures and funding sources are on the manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
NR11 – 1066 (Circ/Ford)
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.